APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Biopharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pet Biopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchPet Biopharmaceuticals Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Biopharmaceuticals Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pet Biopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Biopharmaceuticals Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Biopharmaceuticals Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pet Biopharmaceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pet Biopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Biopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Biopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pet Biopharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Biopharmaceuticals include Merck, Zoetis, Virbac, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Elanco and Dechra Veterinary Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pet Biopharmaceuticals market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Biopharmaceuticals and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Biopharmaceuticals revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pet Biopharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Biopharmaceuticals Segment by Company

Merck

Zoetis

Virbac

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Elanco

Dechra Veterinary Products

Chopperlvya Animal Health

Ceva

CAHIC

Boehringer Ingelheim

Pet Biopharmaceuticals Segment by Type

Antiparasitic

Antibacterial

Biological Products

Others

Pet Biopharmaceuticals Segment by Application

Prevention

Treatment

Pet Biopharmaceuticals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Biopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Biopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Biopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pet Biopharmaceuticals in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Biopharmaceuticals industry.

Chapter 3: Detailed analysis of Pet Biopharmaceuticals companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Biopharmaceuticalsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Biopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Antiparasitic Table 3. Key Players of Antibacterial Table 4. Key Players of Biological Products Table 3. Key Players of Others Table 4. Global Pet Biopharmaceuticals Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Prevention Table 6. Key Players of Treatment Table 7. Global Pet Biopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Pet Biopharmaceuticals Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Pet Biopharmaceuticals Market Share by Region (2021-2026) Table 10. Global Pet Biopharmaceuticals Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Pet Biopharmaceuticals Market Share by Region (2027-2032) Table 12. Pet Biopharmaceuticals Industry Trends Table 13. Pet Biopharmaceuticals Industry Drivers Table 14. Pet Biopharmaceuticals Industry Opportunities and Challenges Table 15. Pet Biopharmaceuticals Industry Restraints Table 16. Global Pet Biopharmaceuticals Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Pet Biopharmaceuticals Revenue Market Share by Company (2021-2026) Table 18. Global Pet Biopharmaceuticals Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Pet Biopharmaceuticals Key Company Head Office and Area Served Table 20. Global Pet Biopharmaceuticals Company, Product Type & Application Table 21. Global Pet Biopharmaceuticals Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Pet Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Pet Biopharmaceuticals Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pet Biopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Pet Biopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Pet Biopharmaceuticals Revenue Market Share by Type (2021-2026) Table 28. Global Pet Biopharmaceuticals Revenue Market Share by Type (2027-2032) Table 29. Global Pet Biopharmaceuticals Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pet Biopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Pet Biopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Pet Biopharmaceuticals Revenue Market Share by Application (2021-2026) Table 33. Global Pet Biopharmaceuticals Revenue Market Share by Application (2027-2032) Table 34. Merck Company Information Table 35. Merck Business Overview Table 36. Merck Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Merck Pet Biopharmaceuticals Product Portfolio Table 38. Merck Recent Development Table 39. Zoetis Company Information Table 40. Zoetis Business Overview Table 41. Zoetis Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Zoetis Pet Biopharmaceuticals Product Portfolio Table 43. Zoetis Recent Development Table 44. Virbac Company Information Table 45. Virbac Business Overview Table 46. Virbac Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Virbac Pet Biopharmaceuticals Product Portfolio Table 48. Virbac Recent Development Table 49. Vetoquinol Company Information Table 50. Vetoquinol Business Overview Table 51. Vetoquinol Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Vetoquinol Pet Biopharmaceuticals Product Portfolio Table 53. Vetoquinol Recent Development Table 54. Ouro Fino Saude Company Information Table 55. Ouro Fino Saude Business Overview Table 56. Ouro Fino Saude Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Ouro Fino Saude Pet Biopharmaceuticals Product Portfolio Table 58. Ouro Fino Saude Recent Development Table 59. Norbrook Company Information Table 60. Norbrook Business Overview Table 61. Norbrook Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Norbrook Pet Biopharmaceuticals Product Portfolio Table 63. Norbrook Recent Development Table 64. Jindun Company Information Table 65. Jindun Business Overview Table 66. Jindun Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Jindun Pet Biopharmaceuticals Product Portfolio Table 68. Jindun Recent Development Table 69. Elanco Company Information Table 70. Elanco Business Overview Table 71. Elanco Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Elanco Pet Biopharmaceuticals Product Portfolio Table 73. Elanco Recent Development Table 74. Dechra Veterinary Products Company Information Table 75. Dechra Veterinary Products Business Overview Table 76. Dechra Veterinary Products Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Dechra Veterinary Products Pet Biopharmaceuticals Product Portfolio Table 78. Dechra Veterinary Products Recent Development Table 79. Chopperlvya Animal Health Company Information Table 80. Chopperlvya Animal Health Business Overview Table 81. Chopperlvya Animal Health Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Chopperlvya Animal Health Pet Biopharmaceuticals Product Portfolio Table 83. Chopperlvya Animal Health Recent Development Table 84. Ceva Company Information Table 85. Ceva Business Overview Table 86. Ceva Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Ceva Pet Biopharmaceuticals Product Portfolio Table 88. Ceva Recent Development Table 89. CAHIC Company Information Table 90. CAHIC Business Overview Table 91. CAHIC Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. CAHIC Pet Biopharmaceuticals Product Portfolio Table 93. CAHIC Recent Development Table 94. Boehringer Ingelheim Company Information Table 95. Boehringer Ingelheim Business Overview Table 96. Boehringer Ingelheim Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Boehringer Ingelheim Pet Biopharmaceuticals Product Portfolio Table 98. Boehringer Ingelheim Recent Development Table 99. North America Pet Biopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 100. North America Pet Biopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 101. North America Pet Biopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 102. North America Pet Biopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 103. North America Pet Biopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Pet Biopharmaceuticals Market Size by Country (2021-2026) Table 105. North America Pet Biopharmaceuticals Market Size by Country (2027-2032) Table 106. Europe Pet Biopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 107. Europe Pet Biopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 108. Europe Pet Biopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 109. Europe Pet Biopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 110. Europe Pet Biopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Pet Biopharmaceuticals Market Size by Country (2021-2026) Table 112. Europe Pet Biopharmaceuticals Market Size by Country (2027-2032) Table 113. China Pet Biopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 114. China Pet Biopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 115. China Pet Biopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 116. China Pet Biopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Pet Biopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 118. Asia Pet Biopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 119. Asia Pet Biopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 120. Asia Pet Biopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 121. Asia Pet Biopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Pet Biopharmaceuticals Market Size by Country (2021-2026) Table 123. Asia Pet Biopharmaceuticals Market Size by Country (2027-2032) Table 124. South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2021-2026) & (US$ Million) Table 127. South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2027-2032) & (US$ Million) Table 128. South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2021-2026) Table 130. South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Pet Biopharmaceuticals Product Image Figure 2. Global Pet Biopharmaceuticals Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pet Biopharmaceuticals Market Share by Type: 2025 VS 2032 Figure 4. Antiparasitic Image Figure 5. Antibacterial Image Figure 6. Biological Products Image Figure 7. Others Image Figure 8. Global Pet Biopharmaceuticals Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Pet Biopharmaceuticals Market Share by Application: 2025 VS 2032 Figure 10. Prevention Image Figure 11. Treatment Image Figure 12. Global Pet Biopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 14. Global Pet Biopharmaceuticals Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Pet Biopharmaceuticals Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Pet Biopharmaceuticals Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Pet Biopharmaceuticals Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pet Biopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 21. Global Pet Biopharmaceuticals Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pet Biopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 23. North America Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 24. North America Pet Biopharmaceuticals Market Share by Type (2021-2032) Figure 25. North America Pet Biopharmaceuticals Market Share by Application (2021-2032) Figure 26. North America Pet Biopharmaceuticals Market Share by Country (2021-2032) Figure 27. United States Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 28. Canada Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 30. Europe Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pet Biopharmaceuticals Market Share by Type (2021-2032) Figure 32. Europe Pet Biopharmaceuticals Market Share by Application (2021-2032) Figure 33. Europe Pet Biopharmaceuticals Market Share by Country (2021-2032) Figure 34. Germany Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 35. France Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 37. Italy Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 38. Russia Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 40. China Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 41. China Pet Biopharmaceuticals Market Share by Type (2021-2032) Figure 42. China Pet Biopharmaceuticals Market Share by Application (2021-2032) Figure 43. Asia Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 44. Asia Pet Biopharmaceuticals Market Share by Type (2021-2032) Figure 45. Asia Pet Biopharmaceuticals Market Share by Application (2021-2032) Figure 46. Asia Pet Biopharmaceuticals Market Share by Country (2021-2032) Figure 47. Japan Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 51. India Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 52. Australia Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pet Biopharmaceuticals Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Pet Biopharmaceuticals Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Pet Biopharmaceuticals Market Share by Country (2021-2032) Figure 57. Brazil Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 62. UAE Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 64. Chile Pet Biopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Antiparasitic
  • Antibacterial
  • Biological Products
  • Others
Applications
  • Prevention
  • Treatment
Companies covered
  • Merck
  • Zoetis
  • Virbac
  • Vetoquinol
  • Ouro Fino Saude
  • Norbrook
  • Jindun
  • Elanco
  • Dechra Veterinary Products
  • Chopperlvya Animal Health
  • Ceva
  • CAHIC
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Antiparasitic
  5. 1.2.3 Antibacterial
  6. 1.2.4 Biological Products
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Prevention
  11. 1.3.3 Treatment
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Pet Biopharmaceuticals Growth Trends by Region
  14. 1.5.1 Global Pet Biopharmaceuticals Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Pet Biopharmaceuticals Market Size by Region (2021-2026)
  16. 1.5.3 Pet Biopharmaceuticals Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Pet Biopharmaceuticals Market Dynamics
  1. 2.1 Pet Biopharmaceuticals Industry Trends
  2. 2.2 Pet Biopharmaceuticals Industry Drivers
  3. 2.3 Pet Biopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Pet Biopharmaceuticals Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pet Biopharmaceuticals Revenue by Company (2021-2026)
  2. 3.2 Global Pet Biopharmaceuticals Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pet Biopharmaceuticals Key Company Head office and Area Served
  4. 3.4 Global Pet Biopharmaceuticals Company, Product Type & Application
  5. 3.5 Global Pet Biopharmaceuticals Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pet Biopharmaceuticals Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pet Biopharmaceuticals Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pet Biopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Pet Biopharmaceuticals Market by Type
  1. 4.1 Global Pet Biopharmaceuticals Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pet Biopharmaceuticals Market Size by Type (2021-2032)
  3. 4.3 Global Pet Biopharmaceuticals Market Size Share by Type (2021-2032)
5 Pet Biopharmaceuticals Market by Application
  1. 5.1 Global Pet Biopharmaceuticals Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pet Biopharmaceuticals Market Size by Application (2021-2032)
  3. 5.3 Global Pet Biopharmaceuticals Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck Pet Biopharmaceuticals Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Zoetis
  8. 6.2.1 Zoetis Company Information
  9. 6.2.2 Zoetis Business Overview
  10. 6.2.3 Zoetis Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Zoetis Pet Biopharmaceuticals Product Portfolio
  12. 6.2.5 Zoetis Recent Developments
  13. 6.3 Virbac
  14. 6.3.1 Virbac Company Information
  15. 6.3.2 Virbac Business Overview
  16. 6.3.3 Virbac Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Virbac Pet Biopharmaceuticals Product Portfolio
  18. 6.3.5 Virbac Recent Developments
  19. 6.4 Vetoquinol
  20. 6.4.1 Vetoquinol Company Information
  21. 6.4.2 Vetoquinol Business Overview
  22. 6.4.3 Vetoquinol Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Vetoquinol Pet Biopharmaceuticals Product Portfolio
  24. 6.4.5 Vetoquinol Recent Developments
  25. 6.5 Ouro Fino Saude
  26. 6.5.1 Ouro Fino Saude Company Information
  27. 6.5.2 Ouro Fino Saude Business Overview
  28. 6.5.3 Ouro Fino Saude Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Ouro Fino Saude Pet Biopharmaceuticals Product Portfolio
  30. 6.5.5 Ouro Fino Saude Recent Developments
  31. 6.6 Norbrook
  32. 6.6.1 Norbrook Company Information
  33. 6.6.2 Norbrook Business Overview
  34. 6.6.3 Norbrook Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Norbrook Pet Biopharmaceuticals Product Portfolio
  36. 6.6.5 Norbrook Recent Developments
  37. 6.7 Jindun
  38. 6.7.1 Jindun Company Information
  39. 6.7.2 Jindun Business Overview
  40. 6.7.3 Jindun Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Jindun Pet Biopharmaceuticals Product Portfolio
  42. 6.7.5 Jindun Recent Developments
  43. 6.8 Elanco
  44. 6.8.1 Elanco Company Information
  45. 6.8.2 Elanco Business Overview
  46. 6.8.3 Elanco Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Elanco Pet Biopharmaceuticals Product Portfolio
  48. 6.8.5 Elanco Recent Developments
  49. 6.9 Dechra Veterinary Products
  50. 6.9.1 Dechra Veterinary Products Company Information
  51. 6.9.2 Dechra Veterinary Products Business Overview
  52. 6.9.3 Dechra Veterinary Products Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Dechra Veterinary Products Pet Biopharmaceuticals Product Portfolio
  54. 6.9.5 Dechra Veterinary Products Recent Developments
  55. 6.10 Chopperlvya Animal Health
  56. 6.10.1 Chopperlvya Animal Health Company Information
  57. 6.10.2 Chopperlvya Animal Health Business Overview
  58. 6.10.3 Chopperlvya Animal Health Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Chopperlvya Animal Health Pet Biopharmaceuticals Product Portfolio
  60. 6.10.5 Chopperlvya Animal Health Recent Developments
  61. 6.11 Ceva
  62. 6.11.1 Ceva Company Information
  63. 6.11.2 Ceva Business Overview
  64. 6.11.3 Ceva Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Ceva Pet Biopharmaceuticals Product Portfolio
  66. 6.11.5 Ceva Recent Developments
  67. 6.12 CAHIC
  68. 6.12.1 CAHIC Company Information
  69. 6.12.2 CAHIC Business Overview
  70. 6.12.3 CAHIC Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 CAHIC Pet Biopharmaceuticals Product Portfolio
  72. 6.12.5 CAHIC Recent Developments
  73. 6.13 Boehringer Ingelheim
  74. 6.13.1 Boehringer Ingelheim Company Information
  75. 6.13.2 Boehringer Ingelheim Business Overview
  76. 6.13.3 Boehringer Ingelheim Pet Biopharmaceuticals Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Boehringer Ingelheim Pet Biopharmaceuticals Product Portfolio
  78. 6.13.5 Boehringer Ingelheim Recent Developments
7 North America
  1. 7.1 North America Pet Biopharmaceuticals Market Size (2021-2032)
  2. 7.2 North America Pet Biopharmaceuticals Market Size by Type
  3. 7.2.1 North America Pet Biopharmaceuticals Market Size by Type (2021-2026)
  4. 7.2.2 North America Pet Biopharmaceuticals Market Size by Type (2027-2032)
  5. 7.2.3 North America Pet Biopharmaceuticals Market Share by Type (2021-2032)
  6. 7.3 North America Pet Biopharmaceuticals Market Size by Application
  7. 7.3.1 North America Pet Biopharmaceuticals Market Size by Application (2021-2026)
  8. 7.3.2 North America Pet Biopharmaceuticals Market Size by Application (2027-2032)
  9. 7.3.3 North America Pet Biopharmaceuticals Market Share by Application (2021-2032)
  10. 7.4 North America Pet Biopharmaceuticals Market Size by Country
  11. 7.4.1 North America Pet Biopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pet Biopharmaceuticals Market Size by Country (2021-2026)
  13. 7.4.3 North America Pet Biopharmaceuticals Market Size by Country (2027-2032)
  14. 7.4.4 North America Pet Biopharmaceuticals Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pet Biopharmaceuticals Market Size (2021-2032)
  2. 8.2 Europe Pet Biopharmaceuticals Market Size by Type
  3. 8.2.1 Europe Pet Biopharmaceuticals Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pet Biopharmaceuticals Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pet Biopharmaceuticals Market Share by Type (2021-2032)
  6. 8.3 Europe Pet Biopharmaceuticals Market Size by Application
  7. 8.3.1 Europe Pet Biopharmaceuticals Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pet Biopharmaceuticals Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pet Biopharmaceuticals Market Share by Application (2021-2032)
  10. 8.4 Europe Pet Biopharmaceuticals Market Size by Country
  11. 8.4.1 Europe Pet Biopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pet Biopharmaceuticals Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pet Biopharmaceuticals Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pet Biopharmaceuticals Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pet Biopharmaceuticals Market Size (2021-2032)
  2. 9.2 China Pet Biopharmaceuticals Market Size by Type
  3. 9.2.1 China Pet Biopharmaceuticals Market Size by Type (2021-2026)
  4. 9.2.2 China Pet Biopharmaceuticals Market Size by Type (2027-2032)
  5. 9.2.3 China Pet Biopharmaceuticals Market Share by Type (2021-2032)
  6. 9.3 China Pet Biopharmaceuticals Market Size by Application
  7. 9.3.1 China Pet Biopharmaceuticals Market Size by Application (2021-2026)
  8. 9.3.2 China Pet Biopharmaceuticals Market Size by Application (2027-2032)
  9. 9.3.3 China Pet Biopharmaceuticals Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pet Biopharmaceuticals Market Size (2021-2032)
  2. 10.2 Asia Pet Biopharmaceuticals Market Size by Type
  3. 10.2.1 Asia Pet Biopharmaceuticals Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pet Biopharmaceuticals Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pet Biopharmaceuticals Market Share by Type (2021-2032)
  6. 10.3 Asia Pet Biopharmaceuticals Market Size by Application
  7. 10.3.1 Asia Pet Biopharmaceuticals Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pet Biopharmaceuticals Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pet Biopharmaceuticals Market Share by Application (2021-2032)
  10. 10.4 Asia Pet Biopharmaceuticals Market Size by Country
  11. 10.4.1 Asia Pet Biopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pet Biopharmaceuticals Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pet Biopharmaceuticals Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pet Biopharmaceuticals Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pet Biopharmaceuticals Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pet Biopharmaceuticals Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pet Biopharmaceuticals Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pet Biopharmaceuticals Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst